DENVER, CO May 3, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), is proud to announce that David Pierce has joined our...
DENVER, CO April 18, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for unsedated Transnasal Endoscopy (TNE), is pleased to announce that Children’s Hospital Los...
DENVER, CO, April 13, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), announced that the company received an investment...
Jonathan T. Hartmann appointed as President and Chief Executive Officer Ryan Hartman appointed as Chief Operating Officer DENVER, CO, April 6, 2023 – EvoEndo®, Inc. (“EvoEndo” or the “Company”), a...
DENVER, CO, EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), is pleased to share recent decisions announced by the Centers for...
BOSTON, October 24, 2022–MedTech Innovator, the largest accelerator of medical devices in the world, and AdvaMed Accel, the leading advocacy association for emerging medtech firms, today announced...
Completes $8.4M Series A Financing to Initiate Rollout of the EvoEndo® Model LE Single-Use Gastroscope Gastroenterologists can now offer pediatric and adult patients a safer, faster, and more...
EvoEndo’s Single-Use Endoscopy System or the “EvoEndo System” eliminates the need for general anesthesia or conscious sedation during routine upper endoscopic procedures The EvoEndo System is...
EvoEndo® and Micro-Tech Endoscopy have signed a distribution agreement for the EvoEndo® Single-Use Endoscopy System, which eliminates the need for general anesthesia during routine endoscopic...
Transnasal Endoscopy (TNE) eliminates the need for general anesthesia during routine endoscopic procedures lowering undue risks, costs, and burdens on patients and facilities DENVER, CO, June 3,...
